Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Jeremie GuedjGéraldine PiorkowskiFrédéric JacquotVincent MadelainThi Huyen Tram NguyenAnne RodallecStephan GuntherCaroline CarbonnelleFrance MentréHervé RaoulXavier de LamballeriePublished in: PLoS medicine (2018)
Our results suggest that favipiravir may be an effective antiviral drug against Ebola virus that relies on RNA chain termination and possibly error catastrophe. These results, together with previous data collected on tolerance and pharmacokinetics in both NHPs and humans, support a potential role for high doses of favipiravir for future human interventions.